Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Stephen MacMillan

Stephen P. MacMillan

Stephen P. MacMillan is the former Chairman of the Board, President, and Chief Executive Officer of Stryker Corporation.

Read More at Wikipedia
Are Boards Getting Too Prudish?

FBN's Liz MacDonald on boards pushing out CEOs for sex scandals.

Read More

  1. Stryker CEO on Impact of New Health-Care Law

    Stryker CEO Stephen MacMillan discusses the new health-care law and the need for tort reform to lower health-care costs.

  2. Stryker CEO: Health Care Needs Rational Debate

    Stryker CEO Stephen MacMillan on Obama's upcoming televised health-care reform meeting next week.

  3. Stryker CEO to FBN:

    February 16, 2010 09:24 PM UTC by Liz ClamanStryker CEO to FBN: "De-politicize Health Care Debate NOW."Only then, says Stephen MacMillan, will we get anywhere in thi...

  1. Stryker 1Q Profit Up 14% On Sales Strength

    DOW JONES NEWSWIRESStryker Corp.'s (SYK) first-quarter earnings rose 14% as the medical-device maker saw sales of its hip and knee replacements increase, providing f...

  2. Stryker Ex-CEO To Get $5.5 Million As Part Of Resignation Agreement

    Stryker Corp.'s (SYK) former chief executive, Stephen P. MacMillan, will receive $5.5 million as part of a resignation agreement, the company disclosed in a filing F...

  3. Stryker Says Interim CEO Hartman To Get $750,000 Annual Salary

    Stryker Corp. (SYK) said Curt Hartman, the company's new interim chief executive, will receive an annual salary of $750,000 in his new post, up from $517,500.In a fi...

  4. Stryker CEO Resignation Represents A Blow In Short Term

    The resignation of Stryker Corp. (SYK) Chief Executive Stephen P. MacMillan leaves a void at the company as it integrates recent acquisitions and grapples with a wea...

  5. Stryker CEO on Health-Care Technology

    Stryker CEO Stephen MacMillan on the company’s growth and its advances in health-care technology.

  6. Stryker 2Q Profit Down 3.1% On Charges; Sales Up

    --MedSurg business fuels double-digit sales gain--Orthopedics market remains challenged; Stryker counting on new products to provide boost--Company backs full-year o...

  7. Stryker Scoops Up Rival Orthovita for $316M

    Stryker (NYSE:SYK) has agreed to buy rival Orthovita (NYSE:VITA) for about $316 million in cash in an effort to expand its existing portfolio of orthopedic products....

Freebase CC-BY
Source: Stephen MacMillan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL